Acute seizure tests in epilepsy research: Electroshock- and chemical-induced convulsions in the mouse

Current Protocols in Pharmacology

Volumn , Issue SUPPL. 45, 2009, Pages

  Giardina, William J ^a   Gasior, Maciej ^b  

^a ABBOTT LABORATORIES   (United States)

^b CEPHALON INC   (United States)

Author keywords

6 Hz; Convulsant; Convulsion; Epilepsy; MES; MEST; Pentylenetetrazol; Seizure

Indexed keywords

8 AZIDO 5,6 DIHYDRO 5 METHYL 6 OXO 4H IMIDAZO[1,5 A][1,4]BENZODIAZEPINE 3 CARBOXYLIC ACID ETHYL ESTER; BICUCULLINE; CARBAMAZEPINE; DIAZEPAM; PENTETRAZOLE; PICROTOXIN; STRYCHNINE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; CALCULATION; CLONIC SEIZURE; DISEASE MODEL; DRUG EFFICACY; DRUG SCREENING; ELECTROSTIMULATION; EXPERIMENTAL MOUSE; MAXIMAL ELECTROSHOCK SEIZURE THRESHOLD TEST; METHODOLOGY; MOUSE; NONHUMAN; PENTETRAZOLE SEIZURE TEST; PHARMACOLOGICAL PROCEDURES; PRIORITY JOURNAL; REPEAT PROCEDURE; REVIEW; SEIZURE; TONIC SEIZURE;

ANIMALS; ANTICONVULSANTS; CONVULSANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DISCOVERY; ELECTROSHOCK; EPILEPSY; MALE; MICE; PENTYLENETETRAZOLE; RATS; SEIZURES;

EID: 66849113785     PISSN: 19348282     EISSN: 19348290     Source Type: Journal    
DOI: 10.1002/0471141755.ph0522s45     Document Type: Review

References (38)

1. Barton, M.E., Klein, B.D., Wolf, H.H., and White, H.S. 2001. Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy. Epilepsy Res. 47:217-227.
2. Barton, M.E., Peters, S.C., and Shannon, H.E. 2003. Comparison of the effect of glutamate receptor modulators in the 6 Hz and maximal electroshock seizure models. Epilepsy Res. 56:17-26.
3. Brown, W.C., Schiffman, D.O., Swinyard, E.A., and Goodman, L.S. 1953. Comparative assay of antiepileptic drugs by "psychomotor" seizure test and minimal electroshock threshold test. J. Pharmacol. Exp. Ther. 107:273-283.
4. Buchhalter, J.R. 1993. Animal models of inherited epilepsy. Epilepsia 34:S31-S41.
5. De Sarro, G., Di Paola, E.D., Gareri, P., Gallelli, L., Scotto, G., and De Sarro, A. 1999. Effects of some AMPA receptor antagonists on the development of tolerance in epilepsy-prone rats and in pentylenetetrazol kindled rats. Eur. J. Pharmacol. 368:149-159.
6. Duncan, G.E. and Kohn, H. 2005. The novel antiepileptic drug lacosamide blocks behavioral and brain metabolic manifestations of seizure activity in the 6 Hz psychomotor seizure model. Epilepsy Res. 67:81-87.
7. Finney, D.J. 1971. Probit Analysis, 3rd edition. Cambridge University Press, Cambridge.
8. Fisher, R.S. 1989. Animal models of the epilepsies. Brain. Res. Brain Res. Rev. 14:245-278.
9. Gasior, M., Ungard, J.T., and Witkin, J.M. 1999. Preclinical evaluation of newly approved and potential antiepileptic drugs against cocaineinduced seizures. J. Pharmacol. Exp. Ther. 290:1148-1156.
10. Gasior, M., Ungard, J.T., Beekman, M., Carter, R.B., and Witkin, J.M. 2000. Acute and chronic effects of the synthetic neuroactive steroid, ganaxolone, against the convulsive and lethal effects of pentylenetetrazol in seizure-kindled mice: Comparisonwith diazepam and valproate. Neuropharmacology 39:1184-1196.
11. Hosford, D.A. and Wang, Y. 1997. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures. Epilepsia 38:408-414.
12. Irwin, S. 1968. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia 13:222-257.
13. Kimball, A.W., Burnett, W.T., and Doherty, D.G. 1957. Chemical protection against ionizing radiation. I. Samplingmethods for screening compounds in radiation protection studies with mice. Radiat. Res. 7:1-12.
14. Krupp, E. and Löscher, W. 1998. Anticonvulsant drug effects in the direct cortical rampstimulation model in rats: Comparison with conventional seizure models. J. Pharmacol. Exp. Ther. 285:1137-1149.
15. Kupferberg, H. 2001. Animal models used in the screening of antiepileptic drugs. Epilepsia 42:7-12.
16. Litchfield, J.T. andWilcoxon, F. 1949. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:99-113.
17. Löscher, W. 1999. Valproate: A reappraisal of its pharmacodynamic properties and mechanisms of action. Prog. Neurobiol. 58:31-59.
18. Löscher, W. 2002. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res. 50:105-123.
19. Mandhane, S.N., Aavula, K., and Rajamannar, T. 2007. Timed pentylenetetrazol infusion test: A comparative analysis with s.c. PTZ and MES models of anticonvulsant screening in mice. Seizure 16:636-644.
20. Matagne, A. and Klitgaard, H. 1998. Validation of corneally kindled mice: A sensitive screening model for partial epilepsy in man. Epilepsy Res. 31:59-71.
21. McIntyre, D.C., Poulter, M.O., and Gilby, K. 2002. Kindling: Some old and some new. Epilepsy Res. 50:79-92.
22. McNamara, J.O. 1986. Kindling model of epilepsy. In Advances in Neurology, Vol. 44 (A.V. Delgado-Escueta, A.A. Ward, Jr., D.M. Woodbury, and R.J. Porter, eds.) pp. 303-318. Raven Press, New York.
23. McNamara, J.O. 1996. Drugs effective in the therapy of the epilepsies. In Goodman Gilman's The Pharmacological Basis of Therapeutics, 9th ed. (J.G. Hardman, L.E. Limbird, P.B. Milinoff, R.W. Ruddon, and A.G. Gilman, eds.) pp. 461- 486. McGraw-Hill, New York.
24. Meldrum, B. 2002. Do preclinical seizure models preselect certain adverse effects of antiepileptic drugs. Epilepsy Res. 50:33-40.
25. Nutt, D.J., Taylor, S.C., and Little, H.J. 1986. Optimizing the pentetrazol infusion test for seizure threshold measurement. J. Pharm. Pharmacol. 38:697-698.
26. Peterson, S.L. and Albertson, T.E. 1998. Neuropharmacology Methods in Epilepsy Research. CRC Press, Boca Raton, Fla.
27. Rogawski, M.A. 2006. Molecular targets versus models for new antiepileptic drug discovery. Epilepsy Res. 68:22-28.
28. Sarkisian, M.R. 2001. Overview of the current animal models for human seizure and epileptic disorders. Epilepsy Behav. 2:201-216.
29. Sarkisian, M.R., Rattan, S., D'Mello, S.R., and LoTurco, J.J. 1999. Characterization of seizures in the flathead rat: A new genetic model of epilepsy in early postnatal development. Epilepsia 40:394-400.
30. Singh, L., Oles, R.J., Vass, C.A., and Woodruff, G.N. 1991. A slow intravenous infusion of Nmethyl- DL-aspartate as a seizure model in the mouse. J. Neurosci. Meth. 37:227-232.
31. Steppuhn, K.G. and Turski, L. 1993. Modulation of the seizure threshold for excitatory amino acids in mice by antiepileptic drugs and chemoconvulsants. J. Pharmacol. Exp. Ther. 265:1063-1070.
32. Swinyard, E.A., Woodhead, J.H., White, H.S., and Franklin, M.R. 1989. General principles. Experimental selection, quantification, and evaluation of anticonvulsants. In Antiepileptic Drugs, 3rd ed. (R. Levy, R. Mattson, B. Medrum, J.K. Penry, and F.E. Dreifuss, eds.) pp. 85-102. Raven Press, New York.
33. Tallarida, R.J. and Murray, R.B. 1987. Manual of Pharmacological Calculations, Second ed. Springer-Verlag, New York.
34. Toman, J.E. 1951. Neuropharmacologic considerations in psychic seizures. Neurology 1:444-460.
35. Toman, J.E., Everett, G.M., and Richards, R.K. 1952. The search for new drugs against epilepsy. Tex. Rep. Biol. Med. 10:96-104.
36. Walton, N.Y., Jaing, Q, Hyun, B., and Treiman, D.M. 1996. Lamotrigine and phenytoin for treatment of status epilepticus: Comparison in an experimental model. Epilepsy Res. 24:19-28.
37. White, H.S. 1999. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. Epilepsia 40:S2-S10.
38. Wlaz, P., Potschka, H., and Löscher, W. 1998. Frontal versus transcorneal stimulation to induce maximal electroshock seizures or kindling in mice and rats. Epilepsy Res. 30:219-29.